DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
4.020
-0.020 (-0.50%)
Nov 20, 2024, 4:00 PM EST - Market closed
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $171.92 million as of November 21, 2024. Its market cap has increased by 79.83% in one year.
Market Cap
171.92M
Enterprise Value
122.09M
1-Year Change
79.83%
Ranking
Category
Stock Price
$4.02
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $171.92M, an increase of 368.45%. That is a compound annual growth rate of 29.60%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 172.80M | 60.30% |
Dec 29, 2023 | 107.80M | 157.89% |
Dec 30, 2022 | 41.80M | -57.61% |
Dec 31, 2021 | 98.60M | -48.11% |
Dec 31, 2020 | 190.00M | 226.46% |
Dec 31, 2019 | 58.20M | 68.70% |
Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Biodesix | 183.29M |
Cellectis | 182.82M |
Caribou Biosciences | 179.29M |
Heron Therapeutics | 177.95M |
BrainsWay | 177.53M |
Nkarta | 175.72M |
Senseonics Holdings | 175.55M |
Actuate Therapeutics | 175.00M |